Results 211 to 220 of about 2,285,924 (374)

Myelodysplastic syndromes: A primary care perspective. [PDF]

S Afr Fam Pract (2004)
Naidoo K, Parasnath S.
europepmc   +1 more source

Myelodysplastic Syndromes [PDF]

Mayo Clinic Proceedings, 2015
openaire   +1 more source

A large long‐term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumours

Internal Medicine Journal, EarlyView.
Abstract Background Gaucher disease (GD) has been variably associated with cancer risk, with conflicting reports in the literature. Understanding the true cancer burden is critical for patient care and genetic counselling. Aim To determine the overall and site‐specific cancer risk in a large, single‐centre GD cohort over three decades.
Majdolen Istaiti, Tama Dinur, Ora Paltiel, Barbara Silverman, Shoshana Revel‐Vilk, Ari Zimran   +5 more
wiley   +1 more source

Somatic mutations in STAG2 are associated with separated megakaryocyte nuclear lobes in myelodysplastic syndromes. [PDF]

Blood Adv
Wong WJ, Zon RL, Gibson CJ, Ho C, Pozdnyakova O, Neuberg D, Battinelli EM, Luskin MR, Tothova Z, Morgan EA, Ebert BL.   +10 more
europepmc   +1 more source

Myelodysplastic syndrome [PDF]

Canadian Medical Association Journal, 2016
Richard A, Wells, Rena, Buckstein, Jeremy, Rezmovitz   +2 more
openaire   +2 more sources

Use of a Foamy‐Virus Vector System to Produce an ‘Off‐the‐Shelf’ Fcγ‐CR‐T Cell Product for the Treatment of Haematological and Solid Tumour Malignancies

Immunology, EarlyView.
Despite the huge success of chimeric antigen receptor (CAR)‐T cells in the treatment of hematologic malignancies, safety concerns have recently been raised in terms of tumorigenesis, relating to the viral vector systems used for product generation, underlying the need for alternative methods for gene modification.
Ioanna Lazana, Emmanouil Simantirakis, Evangelos Kourous, Maria Daniil, Dimitris Ioannou, George Vassilopoulos   +5 more
wiley   +1 more source

Hypermethylation of the p15INK4B Gene in Myelodysplastic Syndromes [PDF]

, 1997
Toshiki Uchida, Tomohiro Kinoshita, Hirokazu Nagai, Y Nakahara, Hidehiko Saito, Tomomitsu Hotta, Takashi Murate   +6 more
openalex   +1 more source

VEXAS Syndrome and Substance Use Disorders: A Large‐Scale, Propensity‐Matched, Case‐Control Analysis Revealing Immune‐Mediated Comorbidities

International Journal of Dermatology, EarlyView.
Kritin K. Verma, Kevin T. Nguyen, Daniel P. Friedmann, Helen Chen, Michelle B. Tarbox   +4 more
wiley   +1 more source

Patient‐Reported Oral Symptoms and Their Impact on Well‐Being After Haematopoietic Cell Transplantation

Oral Diseases, EarlyView.
ABSTRACT Objective Oral complications may negatively influence outcomes of haematopoietic cell transplantation (HCT). A comprehensive view of oral symptoms and symptom burden post‐HCT is lacking. This study aimed to determine the prevalence, severity, and temporal relationships of oral symptoms and their impact on well‐being in the early post‐HCT phase.
Kristina Skallsjö, Michael T. Brennan, Bengt Hasséus, Jenny Öhman, Judith E. Raber‐Durlacher, Marie‐Charlotte D. N. J. M. Huysmans, Alexa M. G. A. Laheij, Stephanie J. M. van Leeuwen, Allan J. Hovan, Karin Garming Legert, Scott Isom, David M. Kline, Nicole M. A. Blijlevens, Jan‐Erik Johansson, Inger von Bültzingslöwen   +14 more
wiley   +1 more source

Burden of Myelodysplastic Syndromes: A Literature Review of Epidemiological and Humanistic Aspects. [PDF]

J Evid Based Med
Xie S, Yan J, Tse P, Humphries B, Xie F.
europepmc   +1 more source